EXACT Therapeutics to present company update

25 Nov 2025 12:57 CET

Oslo, November 25, 2025.

EXACT Therapeutics AS (Euronext Growth, Oslo: EXTX) will be presenting a company
update at the DNB Carnegie Nordic Healthcare Conference on November 25, 2025.

The presentation is attached to this message, and will be made available on the
company’s website www.exact-tx.com/finreports

For further information, please contact:

CEO Per Walday
Per.walday@exact-tx.com


About EXACT-Tx:
EXACT-Tx is a clinical-stage precision medicine company utilizing the power of
ultrasound and microbubbles to enable targeted drug delivery in oncology.
Acoustic Cluster Therapy (ACT®) follows a unique approach and may be applied to
a wide range of therapeutic agents across a multitude of indications including
within oncology (chemotherapy, immunotherapy) and brain diseases.
www.exact-tx.com

More information:
Access the news on Oslo Bors NewsWeb site

660492_251125 Exact Therapeutics - DNB Healthcare conf - non-conf.pdf